Imunon, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Imunon, Inc. (IMNN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 113.70 thousand shares for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-11.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2018-05-11
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-03-31 was 113.70K shares, a 74.97% decline year-over-year.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2017-12-31 was 0.00 shares.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2017-09-30 was 1.19K shares, a 85.24% decline year-over-year.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2017-06-30 was -411.66K shares, a 52809.60% decline year-over-year.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2017 was 43.73K shares, a 1045.80% increase from fiscal 2016.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2016 was 3.82K shares, a 99.14% decline from fiscal 2015.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2015 was 444.18K shares, a 236.89% increase from fiscal 2014.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2014 was 131.85K shares, a 238.32% increase from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2018-03-31 | 113.70K shares 10-Q · filed 2018-05-11 | 113.70K shares derived: sum of 2 quarters · filed 2018-05-11 | 114.89K shares derived: sum of 3 quarters · filed 2018-05-11 | -296.77K shares derived: sum of 4 quarters · filed 2018-05-11 | |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27 | 1.19K shares derived: sum of 2 quarters · filed 2018-03-27 | -410.47K shares derived: sum of 3 quarters · filed 2018-03-27 | 43.73K shares 10-K · filed 2018-03-27 | |
| 2017-09-30 | 1.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -410.47K shares derived: sum of 2 quarters · filed 2017-11-14 | 43.73K shares 10-Q · filed 2017-11-14 | -726.00 shares derived: sum of 4 quarters · filed 2018-03-27 | |
| 2017-06-30 | -411.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 42.55K shares 10-Q · filed 2017-08-14 | -1.92K shares derived: sum of 3 quarters · filed 2018-03-27 | 6.15K shares derived: sum of 4 quarters · filed 2018-03-27 | |
| 2017-03-31 | 454.21K shares 10-Q · filed 2017-05-12 | 409.75K shares derived: sum of 2 quarters · filed 2018-03-27 | 417.81K shares derived: sum of 3 quarters · filed 2018-03-27 | 418.59K shares derived: sum of 4 quarters · filed 2018-03-27 | |
| 2016-12-31 | -44.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27 | -36.40K shares derived: sum of 2 quarters · filed 2018-03-27 | -35.62K shares derived: sum of 3 quarters · filed 2018-03-27 | 3.82K shares 10-K · filed 2018-03-27 | 53.44K shares 10-K · filed 2017-03-24 |
| 2016-09-30 | 8.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 8.85K shares derived: sum of 2 quarters · filed 2016-11-10 | 48.28K shares 10-Q · filed 2016-11-10 | 217.40K shares derived: sum of 4 quarters · filed 2017-03-24 | |
| 2016-06-30 | 781.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | 40.21K shares 10-Q · filed 2016-08-15 | 209.34K shares derived: sum of 3 quarters · filed 2017-03-24 | 282.91K shares derived: sum of 4 quarters · filed 2017-03-24 | |
| 2016-03-31 | 39.43K shares 10-Q · filed 2016-05-16 | 208.55K shares derived: sum of 2 quarters · filed 2017-03-24 | 282.13K shares derived: sum of 3 quarters · filed 2017-03-24 | 478.07K shares derived: sum of 4 quarters · filed 2017-03-24 | |
| 2015-12-31 | 169.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | 242.69K shares derived: sum of 2 quarters · filed 2017-03-24 | 438.64K shares derived: sum of 3 quarters · filed 2017-03-24 | 444.18K shares 10-K · filed 2017-03-24 | |
| 2015-09-30 | 73.57K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 269.51K shares derived: sum of 2 quarters · filed 2015-11-05 | 275.06K shares 10-Q · filed 2015-11-05 | 338.99K shares derived: sum of 4 quarters · filed 2016-03-30 | |
| 2015-06-30 | 195.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 201.49K shares 10-Q · filed 2015-08-10 | 265.42K shares derived: sum of 3 quarters · filed 2016-03-30 | 289.33K shares derived: sum of 4 quarters · filed 2016-03-30 | |
| 2015-03-31 | 5.55K shares 10-Q · filed 2015-05-11 | 69.47K shares derived: sum of 2 quarters · filed 2016-03-30 | 93.39K shares derived: sum of 3 quarters · filed 2016-03-30 | 126.84K shares derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-12-31 | 63.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 87.84K shares derived: sum of 2 quarters · filed 2016-03-30 | 121.30K shares derived: sum of 3 quarters · filed 2016-03-30 | 131.85K shares 10-K · filed 2016-03-30 | |
| 2014-09-30 | 23.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 57.37K shares derived: sum of 2 quarters · filed 2014-11-10 | 67.92K shares 10-Q · filed 2014-11-10 | 71.63K shares derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-06-30 | 33.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | 44.01K shares 10-Q · filed 2014-08-07 | 47.71K shares derived: sum of 3 quarters · filed 2016-03-30 | 119.65K shares derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-03-31 | 10.55K shares 10-Q · filed 2014-05-08 | 14.26K shares derived: sum of 2 quarters · filed 2016-03-30 | 86.19K shares derived: sum of 3 quarters · filed 2016-03-30 | 52.86K shares derived: sum of 4 quarters · filed 2016-03-30 | |
| 2013-12-31 | 3.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 75.64K shares derived: sum of 2 quarters · filed 2016-03-30 | 42.30K shares derived: sum of 3 quarters · filed 2016-03-30 | 38.97K shares 10-K · filed 2016-03-30 | |
| 2013-09-30 | 71.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 38.60K shares derived: sum of 2 quarters · filed 2013-11-12 | 35.27K shares 10-Q · filed 2013-11-12 | 364.25K shares derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-06-30 | -33.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -36.67K shares 10-Q · filed 2013-08-08 | 292.32K shares derived: sum of 3 quarters · filed 2015-03-12 | 248.32K shares derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-03-31 | -3.33K shares 10-Q · filed 2013-05-09 | 325.65K shares derived: sum of 2 quarters · filed 2015-03-12 | 281.65K shares derived: sum of 3 quarters · filed 2015-03-12 | ||
| 2012-12-31 | 328.99K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | 284.99K shares derived: sum of 2 quarters · filed 2015-03-12 | 64.32K shares 10-K · filed 2015-03-12 | 289.42K shares 10-K · filed 2013-03-18 | |
| 2012-09-30 | -44.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -264.67K shares 10-Q · filed 2012-11-09 | |||
| 2012-06-30 | -220.67K shares 10-Q · filed 2012-08-14 | ||||
| 2011-12-31 | 55.59K shares 10-K · filed 2014-03-13 | 250.17K shares 10-K · filed 2013-03-18 | |||
| 2010-12-31 | 130.83K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |